0001193125-11-214529.txt : 20110808 0001193125-11-214529.hdr.sgml : 20110808 20110808172946 ACCESSION NUMBER: 0001193125-11-214529 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20110808 DATE AS OF CHANGE: 20110808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OPHTHALMIC IMAGING SYSTEMS CENTRAL INDEX KEY: 0000885317 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 943035367 STATE OF INCORPORATION: CA FISCAL YEAR END: 0617 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-147680 FILM NUMBER: 111018214 BUSINESS ADDRESS: STREET 1: 221 LATHROP WAY STREET 2: SUITE 1 CITY: SACRAMENTO STATE: CA ZIP: 95815 BUSINESS PHONE: 9166462020 MAIL ADDRESS: STREET 1: 221 LATHROP WAY STREET 2: SUITE 1 CITY: SACRAMENTO STATE: CA ZIP: 95815 FORMER COMPANY: FORMER CONFORMED NAME: OPHTHALMIC IMAGING SYSTEMS INC DATE OF NAME CHANGE: 19930328 RW 1 drw.htm WITHDRAWAL Withdrawal

August 8, 2011

Division of Corporation Finance

Securities and Exchange Commission

100 F. Street, N.E.

Washington, DC 20549

Attention: Kevin Kuhar

Re:  Ophthalmic Imaging Systems

Withdrawal of Post-Effective Amendment No. 6 to Registration Statement on Form S-1 (formerly Form SB-2) (File No. 333-116217), which also serves as Post-Effective Amendment No. 7 to Registration Statement on Form SB-2 (File No. 333-110334) and Post-Effective Amendment No. 1 to Registration Statement on Form SB-2 (File No. 333-147680)

Ladies and Gentlemen:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended (the “Securities Act”), Ophthalmic Imaging Systems (the “Registrant”), hereby requests that the Securities and Exchange Commission (the “Commission”) consents to the withdrawal, effective as of the date hereof or at the earliest practicable date hereafter, of its Post-Effective Amendment No. 6 to Registration Statement on Form S-1 (formerly Form SB-2) (File No. 333-116217), which also serves as Post-Effective Amendment No. 7 to Registration Statement on Form SB-2 (File No. 333-110334) and Post-Effective Amendment No. 1 to Registration Statement on Form SB-2 (File No. 333-147680), together with all exhibits and amendments thereto (collectively, the “Post-Effective Amendment”). The Post-Effective Amendment was originally filed with the Commission on May 9, 2008 and was subsequently amended on May 30, 2008 and September 24, 2009.

The Registrant has determined not to pursue the offerings to which the Registration Statements with Commission File Nos. 333-116217, 333-110334 and 333-147680 relate.

It is our understanding that, pursuant to Rule 477(b) of the Securities Act, this application for withdrawal of the Post-Effective Amendment will be deemed granted as of the date that it is filed with the Commission unless, within 15 calendar days after such date, the Registrant receives notice from the Commission that this application will not be granted.

Please direct any questions regarding the foregoing application for withdrawal to Samuel Schlessinger of McDermott Will & Emery LLP at (312) 984-2090.

Sincerely,

 

Ophthalmic Imaging Systems
By:   /s/ Ann G. Mayberry-French
Name:   Ann G. Mayberry-French
Title:   General Counsel and Corporate Secretary